OSRAM Licht AG の最大収益セグメントは Biopharmaceutical Drugs で、最新の利益発表における収益は 8,392,170 です。地域別に見ると、Australia が OSRAM Licht AG の主要市場であり、収益は 8,392,170 です。
OSRAM Licht AGは収益を上げていますか?
いいえ、最新の財務諸表によると、OSRAM Licht AGの純損失は$-189です。
OSRAM Licht AGに負債はありますか?
はい、OSRAM Licht AGの負債は2,240です。
OSRAM Licht AGの発行済株式数は何株ですか?
OSRAM Licht AGの総発行済株式数は94.18株です。
主要データ
前終値
$51.1
始値
$15.99
当日レンジ
$15.99 - $51.1
52週レンジ
$15.99 - $51.1
取引高
10
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
-1.94
時価総額
$152.9B
OSRAM LICHT AG UNSP ADR EA REPRとは何ですか?
OSRAM Licht AG engages in the manufacture and sale of lighting products. The company is headquartered in Muenchen, Bayern and currently employs 22,042 full-time employees. The company went IPO on 2013-07-08. The firm has three segments. The Opto Semiconductors segment develops products relating to optoelectronic semiconductor technology, such as light-emitting diodes (LEDs), optical sensors, infrared LEDs and laser diodes, among others. The Specialty Lighting segment offers lamps and systems for the automotive sector, stage and cinema applications, and industrial and medical applications, such as ultraviolet (UV) disinfection lamps. The Lighting Solutions & Systems segment is divided into two business units: Digital Systems develops LED light engines, electronic ballasts for LED modules and traditional lamps, and light management software with application in intelligent facility automation and the Internet of Things (IoT), and Lighting Solutions produces and sells luminaires as well as designs and implements solutions for internal and external lighting.